Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 54,147 | 46,464 | 45,315 | 35,420 |
| Receivables | N/A | 65,310 | 72,984 | 95,942 | 68,324 |
| Other current assets | 0 | 78,992 | 393,522 | 525,705 | 30,063 |
| TOTAL | $N/A | $214,662 | $520,819 | $668,487 | $138,065 |
| Non-Current Assets | |||||
| PPE Net | N/A | 1,781,321 | 1,820,735 | 1,816,794 | 2,005,299 |
| Investments And Advances | 0 | 550,573 | 495,488 | 473,792 | 246,450 |
| Intangibles | 0 | 0 | 0 | 21,527 | 23,517 |
| Other Non-Current Assets | 0 | 66,076 | 64,723 | 32,017 | 14,797 |
| TOTAL | $N/A | $2,397,970 | $2,380,946 | $2,344,130 | $2,290,063 |
| Total Assets | $N/A | $2,612,632 | $2,901,765 | $3,012,617 | $2,428,128 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 183,448 | 218,094 | 311,381 | 132,049 |
| Accounts payable and accrued liabilities | 0 | 104,175 | 29,671 | 81,510 | 102,091 |
| Accrued Expenses | N/A | 29,598 | 25,206 | 25,069 | 15,706 |
| Other current liabilities | N/A | N/A | 8,752 | N/A | N/A |
| TOTAL | $N/A | $320,250 | $288,128 | $425,533 | $257,657 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,562,283 | 1,880,122 | 1,847,633 | 1,570,773 |
| Deferred Revenues | N/A | 3,029 | 6,405 | 7,573 | 7,811 |
| Other Non-Current Liabilities | 0 | 3,417 | 4,899 | 0 | 0 |
| TOTAL | $N/A | $1,590,142 | $1,920,397 | $1,885,952 | $1,606,626 |
| Total Liabilities | $N/A | $1,910,392 | $2,208,525 | $2,311,485 | $1,864,283 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 17,285 | 17,487 | 18,712 | 20,491 |
| Common Shares | N/A | 2 | 2 | 2 | 2 |
| Retained earnings | N/A | 503,321 | 493,294 | 471,112 | 397,640 |
| Other shareholders' equity | 0 | 98,122 | 97,235 | 97,352 | -6,122 |
| TOTAL | $N/A | $702,240 | $693,240 | $701,132 | $563,845 |
| Total Liabilities And Equity | $0 | $2,612,632 | $2,901,765 | $3,012,617 | $2,428,128 |